QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
(Is 98% rate of non-recurrence a realistic goal?) Why a patient’s column? This is not a doctors column. I am a patient of Dr. Catalona and a member of the URF Board. This column attempts to provide a patients perspective…
Each year, Dr. Catalona and his research collaborators deliver their research findings at the American Urological Association (AUA) annual meeting. In the last issue of QUEST, we summarized findings from recent research projects of Dr. Catalona and his collaborators. The…
John Clark is an athlete a middle-aged athlete who was treated for prostate cancer last year. His career, until he retired at 54, was athletic director for St. Lawrence University. His children, seven of them, are athletes too. Naturally…
Misop Han, M.D.; Peter H. Gann, M.D., Sc.D.; William J. Catalona, M.D. prepared a paper on PSA and Screening for Prostate Cancer for the journal Medical Clinics of North America. This article is a portion of that paper revised by…
Dear Readers of Quest and Friends Of the Urological Research Foundation When Dr. Catalona developed the PSA test, he transformed the way prostate cancer was diagnosed, allowing for earlier detection and the saving of thousands of lives. Now, he and…
Why a patient’s column? This is not a doctor’s column. I am a patient of Dr. Catalona and a member of the URF Board. This column attempts to provide a patient’s perspective on prostate cancer to the readers of QUEST….
Each year, Dr. Catalona and his research collaborators deliver their research findings at the annual meeting of the American Urological Association (AUA). Although the information is technical, we feel that Quest readers would like to be familiar with the direction…
Even when the pathology report after a radical prostatectomy states that it looks like all of the cancer was confined to the prostate gland, some percentage of men have a recurrence of the cancer at a later date. In these…
Much publicity has been given to a new study suggesting that biopsies should be recommended for men whose PSA tests 2.6 or higher. (We introduced the study in the Fall 2003 QUEST and cover it extensively in this Winter 2003…
Doctors and patients alike hope that removing the prostate, a radical prostatectomy (RP), will be a successful, life-long treatment for prostate cancer. Still, patients need to be informed of recommended further testing after the surgery and preventative postoperative treatments connected…
"*" indicates required fields
